On Air Now

Game On

7:00pm - 10:00pm


You are viewing content from Nigeria Info, Let's Talk! Lagos. Would you like to make this your preferred location?

Affordability is a critical issue when it comes to PrEP, as it must be taken daily in order to be effective

PrEP stands for pre-exposure prophylaxis. It is an HIV prevention strategy that involves taking medication before potential exposure to HIV in order to reduce the risk of infection. The medication used for PrEP is typically a combination of two antiretroviral drugs, tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC), sold under the brand name Truvada.

PrEP is recommended for people, who are at high risk of HIV infection, including:

1. Men who have sex with men

2. People who inject drugs

3. Sex workers

4. Transgender individuals

5. Individuals in serodiscordant couples (where one partner is HIV-positive and the other is HIV-negative)

When taken consistently, PrEP can be highly effective in reducing the risk of HIV infection. Studies have shown that daily PrEP can reduce the risk of HIV infection by up to 99% in some populations.

It is important to note that PrEP is not a cure for HIV and does not protect against other sexually transmitted infections (STIs). PrEP is also not recommended as a sole method of HIV prevention and should be used in conjunction with other prevention strategies, such as condom use and regular HIV testing.


Is Affordability A Concern With PrEP?

Affordability is a critical issue when it comes to PrEP, as it must be taken daily in order to be effective, potentially creating a significant cost burden for those who need it. The cost of PrEP can vary widely depending on a number of factors, including location, insurance coverage, and specific medication used.

To address affordability concerns, a range of strategies have been proposed and implemented, including:

Insurance coverage: Many insurance plans now cover the cost of PrEP, making it more affordable for those who have access to insurance. In some cases, patient assistance programs may also be available to help cover the cost of PrEP for those who are uninsured or underinsured.

Generic versions: Generic versions of PrEP medications have become available in some regions, which can reduce the cost of the medication.

Price negotiation: Efforts to negotiate lower prices for PrEP medications can help make the treatment more affordable, particularly in low- and middle-income countries.

Donation programs: Some pharmaceutical companies and public health organizations the world over have established donation programs to provide free or low-cost PrEP to those who need it.

Education and awareness: Increasing awareness of PrEP and its benefits can help reduce stigma and increase demand, potentially leading to lower prices through increased competition.

Overall, addressing affordability concerns will be critical to ensuring that PrEP is accessible to all who need it. This will require continued efforts to reduce the cost of PrEP medications and ensure that insurance coverage or other assistance programs are available to those who need them.

Awareness is also an important factor when it comes to HIV prevention, including PrEP. Many people who are at high risk of HIV infection may not be aware of PrEP as a prevention option or may not have access to accurate information about it. Increasing awareness of PrEP can help ensure that those who could benefit from it are aware of its potential benefits and how to access it.

How Do You Increase Awareness Of PrEP?

Education campaigns: Education campaigns in conventional and social media can help raise awareness of PrEP among high-risk populations, healthcare providers, and the general public. These campaigns can use a variety of media (including social media, print materials, and public service announcements) to achieve best results.

Peer education: Peer educators, who are individuals from within high-risk populations who have received training on PrEP and HIV prevention, can be effective in reaching and educating others within their communities.

Healthcare provider training: Healthcare providers can play an important role in increasing awareness of PrEP by providing accurate information to their patients and offering PrEP as a prevention option to those who are at high risk of HIV infection.

Community engagement: Engaging with high-risk communities through community events and other outreach efforts can help increase awareness of PrEP and promote its use as a prevention option.

Stigma reduction: Reducing stigma surrounding HIV and high-risk populations can also be important in increasing awareness and uptake of PrEP.

Increasing awareness of PrEP will require a sustained effort, but can be an important step in reducing the incidence of HIV infection and improving the health of those who are at high risk.


In addition research has been and is still ongoing in the area of HIV prevention. Some areas of research that are currently being explored include:

Alternative delivery methods: While oral PrEP is the most commonly used form of the treatment, research is underway to explore alternative delivery methods, such as long-acting injectable and implantable devices. These alternative methods could potentially reduce the burden of daily adherence and increase the effectiveness of PrEP.

New medications: While the combination of TDF and FTC is currently the most commonly used medication for PrEP, research is underway to explore the effectiveness of other medications for HIV prevention.

Efficacy in different populations: While PrEP has been shown to be highly effective in reducing the risk of HIV infection in many populations; research is ongoing to explore its efficacy in different populations, such as adolescents and transgender individuals.

Adherence support: Improving adherence to PrEP is a critical factor in its effectiveness. Research is also in advanced stages to explore new strategies for supporting adherence, such as digital health interventions and peer support programs.

Implementation and access: Ensuring that PrEP is accessible to those who need it is an ongoing challenge. Research is exploring strategies for improving implementation and access to PrEP, particularly in low- and middle-income countries.

Overall, ongoing research is critical in improving our understanding of PrEP and developing new strategies to improve its effectiveness and accessibility.


Peculiar PrEP Problems in Sub-Saharan Africa

Sub-Saharan Africa faces several unique challenges when it comes to HIV prevention and the use of PrEP. Some of these challenges include:

Limited access to healthcare: Many people in sub-Saharan Africa do not have access to healthcare services, which can limit their ability to access PrEP and other HIV prevention methods.

Stigma and discrimination: Stigma and discrimination surrounding HIV and high-risk populations can be particularly acute in sub-Saharan Africa and cannot be over emphasized, which can make it difficult to increase awareness of PrEP and encourage its use.

Lack of awareness and education: Many people in sub-Saharan Africa are not aware of PrEP as a prevention option, and may not have access to accurate information about how to use it or where to access it.

Limited funding and resources: Many countries in sub-Saharan Africa have limited funding and resources for HIV prevention and treatment due to mismanagement of state funds and endemic corruption, which can limit the availability of PrEP and other prevention methods.

Limited healthcare infrastructure: The healthcare infrastructure in many parts of sub-Saharan Africa is underdeveloped, which can make it difficult to deliver and monitor PrEP services.

Addressing these challenges will require a concerted effort from governments, healthcare providers, community organizations, and other stakeholders. Strategies for improving access to PrEP in sub-Saharan Africa may include increasing funding for HIV prevention and treatment programs, expanding healthcare infrastructure, and improving education and awareness around PrEP and other HIV prevention methods.

While there are certainly challenges to be faced in the area of HIV prevention, there is also reason for hope.

Significant progress has been made in recent years in improving access to PrEP and other prevention methods, and there is ongoing research and development in this area.

For example, some countries in sub-Saharan Africa have made significant strides in expanding access to PrEP. South Africa, for instance, has launched a national PrEP program and has made the medication available at no cost to eligible individuals. In addition, efforts are underway to increase awareness and education around PrEP in many countries, with community organizations and healthcare providers playing a critical role in these efforts.

In addition, ongoing research is exploring new approaches to HIV prevention, including the development of new medications and delivery methods. Long-acting injectable PrEP, for instance, is currently being studied and could potentially offer an alternative to daily oral medication.

Overall, while there is still work to be done, there are many reasons for hope when it comes to HIV prevention and the use of PrEP. With continued efforts and investments in this area, it is possible to significantly reduce the incidence of new HIV infections and improve the lives of those living with the virus.

How accepted is this innovation?

Acceptance of PrEP and other HIV prevention methods has been influenced by a variety of factors, including cultural beliefs, access to healthcare, education, and awareness.

One of the challenges to acceptance of PrEP is stigma and discrimination surrounding HIV, which can lead to reluctance to seek testing and care. This stigma can also extend to the use of prevention methods like PrEP, particularly among certain populations such as men who have sex with men, commercial sex workers, and people who inject drugs.

Education and awareness campaigns can help to increase acceptance of PrEP by dispelling myths and misconceptions, and by providing accurate information about the medication and how it works. Healthcare providers also play a critical role in increasing acceptance of PrEP by providing clear and accurate information about the medication, and by ensuring that patients feel comfortable discussing their risk factors and options for prevention.

Access to PrEP can also play a role in acceptance, as individuals who are unable to access the medication may be less likely to consider using it. Governments, healthcare providers, and community organizations can work to increase access to PrEP by promoting policies and programs that make the medication available and affordable to those who need it.

Overall, increasing acceptance of PrEP will require a multi-faceted approach that addresses cultural attitudes, stigma and discrimination, education and awareness, and access to healthcare and prevention services.

Role of the Government

Governments have a critical role to play in addressing the challenges associated with HIV prevention and increasing access to PrEP. Some of the key actions that governments can take include:

Funding and supporting HIV prevention programs:-

Funding and resources can be allocated   to support HIV prevention programs, including those that promote PrEP and other prevention methods.

Creating enabling policies and guidelines:-

Policies and guidelines can be created to promote the use of PrEP and ensure that it is accessible to those who need it. This can include making PrEP available in public healthcare facilities and ensuring that it is affordable.


New trends in HIV prevention and treatment:

Long-acting antiretroviral drugs: Researchers are exploring the use of long-acting antiretroviral drugs, which could reduce the need for daily medication and improve adherence to treatment.

Multi-purpose prevention technologies (MPTs): MPTs are products that can prevent multiple health issues, such as HIV and other STIs. Examples include vaginal rings that contain both a contraceptive and an HIV prevention drug.

HIV self-testing: HIV self-testing allows individuals to test for HIV in the privacy of their own home, which could improve access to testing and reduce stigma.

Community-based models of care: Community-based models of care involve engaging affected communities in the delivery of HIV prevention and treatment services. This approach has shown promise in improving access to care and reducing stigma.

Combination prevention approaches: Combination prevention approaches involve using multiple prevention strategies, such as PrEP, condoms, and behavioral interventions, to reduce the risk of HIV transmission. This approach may be more effective than any single intervention alone.

Digital health technologies: Digital health technologies, such as mobile apps and online platforms, can improve access to information and services related to HIV prevention and treatment. For example, some apps provide information on local HIV testing sites and prevention services, while others provide reminders to take medication or attend appointments.


  • Lagos Weather

    Sunny intervals

    High: 35°C | Low: 28°C